<DOC>
	<DOC>NCT03078569</DOC>
	<brief_summary>This study evaluates the efficacy of pre- IVF treatment with transdermal testosterone to enhance ovarian response in poor responders. a randomized controlled trial with two groups, treatment group with transdermal testosterone before IVF treatment and a control group with no treatment.</brief_summary>
	<brief_title>Transdermal Testosterone for Poor Responder Patients Undergoing Controlled Ovarian Stimulation Prior to IVF</brief_title>
	<detailed_description>One of the major challenges of Assisted reproduction technology is treating women with low ovarian response,those women achieve very poor pregnancy rate with IVF. in recent years there is a focus</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility, Female</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>infertility patients undergoing ART regular menses normal function of thyroid, liver and kidney normal BMI (19.328.9) without use of any fertility drugs in the previous two months patients with recurrent implantations failure (3 cycles and more) previous ovarian surgery uncontrolled medical illness severe endometriosis (stage 34) contraindication for testosterone use</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Poor responders</keyword>
</DOC>